Re: Add one to the list

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2666 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Add one to the list

in response to

Add one to the list

jonzobot

posted on Sep 12, 2023 07:21PM

I don't understand how Zenith epigenetics is not listed as a sponsor or collaborator in this new trial.. The Fact that Zenith owns the IP to ZEN3694 you would think they would want some acknowledgement and guidance in the trial?

Can anyone give a logical reason for the Zen not to be involved? i get it they are not paying for the trial but still???

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply